For the quarter, the Voya MidCap Opportunities Fund underperformed the Index on a NAV basis due largely to selection effects.

The de-escalation of therapy helps avoid unnecessary toxicity from treatment in patients with brain cancer, explained Drs.

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...

China’s AI upstart DeepSeek shook the tech industry and stock markets earlier this year by proving to be amazingly capable despite accessing relatively limited resources, such as chips. It has gone on ...

DeepSeek's advancements were inevitable, but the company brought them forward a few years earlier than would have been possible otherwise.

University of Cincinnati discusses the potential of agentic AI, autonomous systems capable of acting with minimal human ...

Researchers uncover the genetic blueprint for coral chemicals with anti-cancer and anti-inflammatory properties Some corals produce chemicals called diterpenoids that have shown promise in fighting ...

By removing the pull of gravity, space has accelerated breakthroughs once thought impossible, reshaping medicine, ...

Yep, Google and Microsoft are ahead now, but taking the time to deliver a thoughtful, truly useful AI approach is very Apple, and it's ultimately the right move.

From "fast-follow" to "first-in-class/best-in-class", Chinese R&D teams have repeatedly set new records in global clinical ...

Chinese mid-cap stocks will be the next winners as companies take advantage of advancements in artificial intelligence, ...

A clinical trial led by London Health Sciences Centre Research Institute (LHSCRI) and Western University's Schulich School of ...